BIT 5.00% 1.9¢ biotron limited

capital raising ahead

  1. 409 Posts.
    lightbulb Created with Sketch. 4
    General increase in biotechs today.
    BIT will need to raise capital shortly to purchase the sofosbuvir for the G3 DAA trial. 50 patients for 3 months will be ~5 million AUD. Plus trial costs. Interesting to see what the raise is priced at.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.